Clinical Trials Browser

Phase 3 × OTHER × 5-aminolevulinic acid hexyl ester × Clear all

NCT06525571 2025-11-18

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

Phase 3 Recruiting

Urinary Bladder Neoplasms

NCT02660190 2019-08-14

DaBlaCa-11

Phase 3 Completed

Urinary Bladder Neoplasms, Recurrence